Calidi Biotherapeutics CLDI
NYSE CLDI
$0.68 -0.02 (-2.86%)
At close: Nov 11, 2026 · 4:00 PM EST

Calidi Biotherapeutics (CLDI) Gains (Losses) on Sale of Assets & Investments (2021 - 2023)

Updated

Calidi Biotherapeutics (CLDI) recorded Non Operating Investment Income of $244,000 in FY2025.

Analysis

Calidi Biotherapeutics (CLDI) Gains (Losses) on Sale of Assets & Investments (2021 - 2023) Analysis & Trends

  • Annual Non Operating Investment Income has a four-year compound annual growth rate of 197.5% (FY2021 to FY2025).
  • The FY2025 figure is the lowest annual Non Operating Investment Income since FY2021.
  • Per Business Quant data, CLDI's Non Operating Investment Income was $3,115 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Calidi Biotherapeutics 991,199.98 -25.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 12,848.00
Mar 31, 2023 27,986.00
Mar 31, 2022 2,266.00
Sep 30, 2021 423.00
API Access

Calidi Biotherapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CLDI&period=max&api_key=YOUR_API_KEY